Ezplex® SARS-CoV-2 G

FDA Emergency Use Authorization (EUA)
CE IVD
Korean MFDS

The Ezplex SARS-CoV-2 G Kit is real-time RT-PCR in vitro diagnostic test intended for the qualitative detection of nucleic acid from SARS-CoV-2 (RdRp and N genes) in individuals suspected of COVID-19 by their healthcare provider (nasopharyngeal and oropharyngeal swabs and sputum).

The test can be quickly and accurately completed through PCR with extracted RNA, and the results can be conveniently viewed using Genetree Viewer assay software.

Fast Results

Produces test results within 2.5 hours post extraction.

Real-time PCR

Detection and identification of target genes (RdRP, N) specific for COVID-19 in a single tube.

Sensitivity

eference material was repeatedly tested through serial dilution to show high analytical sensitivity. FDA SARS-CoV-2 Reference Panel detection limit of 1200 NDU*/mL.
NAAT Detectable Units/mL